智云健康2024年营收34.9亿元 P2M业务同比激增182.4%
南方财经3月31日电，智云健康（09955.HK）发布2024年度业绩公告。全年营收达34.9亿元人民币，毛利率稳中略升，达24.7%。而净亏损扩大主要源于非核心业务处置的一次性影响，并非经营性原因。 财报指出，短期发展策略上，公司将重点推进“AI SaaS+P2M”（从患者到工业）战略，通过自营药品销售确保现金流稳定；中期计划，将依托医疗数据资产构建商业化变现模型；长期目标则是整合医院、药店、药企、患者及支付方等医疗生态各方资源，打造个人慢病管理闭环。（21世纪经济报道）
（文章来源：南方财经网）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10